Status:
COMPLETED
Evaluation of Decision Compatibility Between a Multidisciplinary Cancer Board and ChatGPT-4O
Lead Sponsor:
Sebahattin Celik MD
Conditions:
Cancer
Artificial Intelligence
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to compare the decisions of a multidisciplinary cancer board at Van research and educational Hospital with those generated by ChatGPT-4O. Patient data, including age, gender, comorbidi...
Detailed Description
This study aims to evaluate the agreement between decisions made by a multidisciplinary cancer board at Van Hospital and those generated by the ChatGPT-4O model. A total of 100 cancer patients presen...
Eligibility Criteria
Inclusion
- above 18 y/o
- patients diagnosed with malignancy
Exclusion
- patients who refused to consent
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06986564
Start Date
November 1 2024
End Date
May 1 2025
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Van state hospital, general surgery department
Van, Turkey (Türkiye), 6500